Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Omecamtiv mecarbil improves left atrial contractility in healthy males

Sep. 14, 2010

New partial 5-HT3 receptor agonist described for treatment of IBS

Sep. 14, 2010

MEDI-578 has analgesic effects in rat model of inflammatory pain

Sep. 14, 2010

New dual mTOR/PI3K-alpha inhibitor PF-04979064 may advance to clinic as anticancer agent

Sep. 14, 2010

Vardenafil improves exercise capacity in phase III trial in subjects with PAH

Sep. 14, 2010

New histamine H4 receptor ligand VUF-11488 to be tested in inflammation models

Sep. 13, 2010

Intranasal desmopressin ineffective in relieving renal colic pain

Sep. 13, 2010

INNOVATE-PCI trial data support entry of antiplatelet agent elinogrel in phase III trial

Sep. 13, 2010

Pharmacological profile supports evaluation of GSK-1427400 in chronic pain

Sep. 13, 2010

New gamma-secretase modulators show favorable properties in preclinical evaluation

Sep. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...